Pacific Biosciences of California (PACB) 8-K Results of Operations and Financial Condition

Exhibit 99.1

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Condensed Consolidated Balance Sheets

(Unaudited)

	September 30,		December 31,
(in thousands except par value amounts)	2015		2014
Assets
Current assets
Cash and cash equivalents	$	27,208	$	36,449
Investments		31,701		64,899
Accounts receivable		4,164		3,406
Inventory		11,621		11,335
Prepaid expenses and other current assets		11,513		1,671
Total current assets		86,207		117,760
Property and equipment, net		7,855		6,601
Other long-term assets		5,715		162
Total assets	$	99,777	$	124,523
Liabilities and Stockholders' Equity
Current liabilities
Accounts payable	$	6,097	$	5,608
Accrued expenses		11,342		11,441
Deferred service revenue, current		6,303		6,121
Deferred contractual revenue, current		14,385		6,785
Other liabilities, current		627		1,534
Total current liabilities		38,754		31,489
Deferred service revenue, non-current		1,250		1,129
Deferred contractual revenue, non-current		1,347		19,735
Other liabilities, non-current		1,323		2,153
Notes payable		14,808		14,124
Financing derivative		925		944
Total liabilities		58,407		69,574
Commitments and contingencies
Stockholders’ equity
Preferred Stock, $0.001 par value:
Authorized 50,000 shares; No shares issued or outstanding		—		—
Common Stock, $0.001 par value:
Authorized 1,000,000 shares; Issued and outstanding 75,705 shares at September 30, 2015 and 73,927 shares at December 31, 2014		76		74
Additional paid-in capital		753,048		736,339
Accumulated other comprehensive income		6		9
Accumulated deficit		(711,760)		(681,473)
Total stockholders’ equity		41,370		54,949
Total liabilities and stockholders’ equity	$	99,777	$	124,523